Status:
UNKNOWN
Liver Diseases in PLWH
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
HIV/AIDS
Liver Diseases
Eligibility:
All Genders
18+ years
Brief Summary
In Highly Active Antiretroviral Therapy era, fatty liver has become an important cause of liver function damage in people living with HIV (PLWH). There are a large number of PLWH in China who are infe...
Eligibility Criteria
Inclusion
- Age ≥18 years old;
- Non-hospitalized patients diagnosed with HIV infection;
- Sign the informed consent voluntarily.
Exclusion
- Severe active infection requiring parenteral antibiotics or antifungal treatment within 30 days before the assessment;
- Other major chronic diseases that may affect health-related quality of life, such as extrahepatic malignant tumors;
- Psychotic patients, patients with severe cognitive or neurological deficits;
- Women during pregnancy and lactation;
- Those who refuse to sign informed consent.
Key Trial Info
Start Date :
May 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04446156
Start Date
May 26 2020
End Date
December 30 2020
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the first affiliated hospital of Zhejiang university school of medicine
Hangzhou, Zhejiang, China, 310000